Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinay Kumar Rao

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Epigenetics|January 21, 2017
A drive in SUVs: From development to diseaseVinay Kumar Rao, Ananya Pal, Reshma Taneja
Cancers|September 9, 2022
Cancer Cachexia: Signaling and Transcriptional Regulation of Muscle Catabolic GenesVinay Kumar Rao, Dipanwita Das, Reshma Taneja
Methods in Molecular Biology (Clifton, N.J.)|October 28, 2018
Chromatin Immunoprecipitation in Skeletal MyoblastsVinay Kumar Rao, Shilpa Rani Shankar, Reshma Taneja
Recent Advances in Drug Delivery and Formulation|May 19, 2026
Solid Lipid Nanoparticles (SLNPs): Advanced Potential Carriers for Targeting Antipsychotic Medications in the Treatment of Psychotic DisordersVinay Kumar Rao Khadam, Himmat Singh Chawra, Ravindra Pal Singh
Experimental and Molecular Pathology|December 16, 2025
Understanding diabetes and its complications through the lens of DrosophilaSupriya Bevinakoppamath, Anju Srinivas, Chandan Gowda Umesha, et al.
Journal of Molecular Cell Biology|October 10, 2017
GLP inhibits heterochromatin clustering and myogenic differentiation by repressing MeCP2Min Hee Choi, Monica Palanichamy Kala, Jin Rong Ow, et al.
Scientific Reports|September 27, 2016
G9a inhibits MEF2C activity to control sarcomere assemblyJin Rong Ow, Monica Palanichamy Kala, Vinay Kumar Rao, et al.
Epigenetics|December 22, 2012
G9a, a multipotent regulator of gene expressionShilpa Rani Shankar, Avinash G Bahirvani, Vinay Kumar Rao, et al.
Nucleic Acids Research|May 28, 2016
G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiationVinay Kumar Rao, Jin Rong Ow, Shilpa Rani Shankar, et al.
Vaccines|October 27, 2022
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine EffectivenessSubbaRao V Tulimilli, Siva Dallavalasa, Chaithanya G Basavaraju, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Epigenetics|January 21, 2017
A drive in SUVs: From development to diseaseVinay Kumar Rao, Ananya Pal, Reshma Taneja
Cancers|September 9, 2022
Cancer Cachexia: Signaling and Transcriptional Regulation of Muscle Catabolic GenesVinay Kumar Rao, Dipanwita Das, Reshma Taneja
Methods in Molecular Biology (Clifton, N.J.)|October 28, 2018
Chromatin Immunoprecipitation in Skeletal MyoblastsVinay Kumar Rao, Shilpa Rani Shankar, Reshma Taneja
Recent Advances in Drug Delivery and Formulation|May 19, 2026
Solid Lipid Nanoparticles (SLNPs): Advanced Potential Carriers for Targeting Antipsychotic Medications in the Treatment of Psychotic DisordersVinay Kumar Rao Khadam, Himmat Singh Chawra, Ravindra Pal Singh
Experimental and Molecular Pathology|December 16, 2025
Understanding diabetes and its complications through the lens of DrosophilaSupriya Bevinakoppamath, Anju Srinivas, Chandan Gowda Umesha, et al.
Journal of Molecular Cell Biology|October 10, 2017
GLP inhibits heterochromatin clustering and myogenic differentiation by repressing MeCP2Min Hee Choi, Monica Palanichamy Kala, Jin Rong Ow, et al.
Scientific Reports|September 27, 2016
G9a inhibits MEF2C activity to control sarcomere assemblyJin Rong Ow, Monica Palanichamy Kala, Vinay Kumar Rao, et al.
Epigenetics|December 22, 2012
G9a, a multipotent regulator of gene expressionShilpa Rani Shankar, Avinash G Bahirvani, Vinay Kumar Rao, et al.
Nucleic Acids Research|May 28, 2016
G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiationVinay Kumar Rao, Jin Rong Ow, Shilpa Rani Shankar, et al.
Vaccines|October 27, 2022
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine EffectivenessSubbaRao V Tulimilli, Siva Dallavalasa, Chaithanya G Basavaraju, et al.
Pageof 2